Thus, as abrogation of IRE1α in mice results in this broad range of metabolically beneficial effects, we suggest that it would be worthwhile exploring the role of the IRE-1α pharmacological inhibitor STF083010 by delivering it specifically to macrophages with the aim of reducing obesity. Here, ERN1 is linked to obesity disorder.